Our offshore IT consulting services along with the AI-powered core helps top companies stay competitive, win new markets and increase shareholder value.
Have you noticed that pharmaceutical organisations are shifting manual tasks to AI solutions? Organisations that run manual clinical trials and traditional drug discovery are facing challenges like high cost, time-consuming processes, and risks. It's a fact that the days of manual clinical trials and drug discovery are gone.
HIPAA-compliant AI development' is a hot topic that is changing the whole scenario in the healthcare sector. Today, healthcare AI solutions are getting more popular, and most of the healthcare services consider AI solutions as a first priority. That's why almost 70% of healthcare services use at least one AI solution, and the global market is expected to reach $505+ billion by 2033.
Today, AI is one of the most implemented technologies in healthcare organisations. Data says that more than 70% of healthcare organisations use at least one AI healthcare solution but struggle to calculate their financial and operational impact. They raise the common questions: How to measure the return on your AI investment? Is your healthcare AI investment beneficial? Or does healthcare AI development bring constant ROI?